Status:
COMPLETED
(TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery
Lead Sponsor:
Jörg Schefold
Conditions:
Renal Failure
Dialysis
Eligibility:
All Genders
18+ years
Brief Summary
New biomarkers that predict the development of renal dysfunction in patients with aortic surgery are urgently needed. The investigators investigate whether urinary (TIMP-2)x(IGFBP7) predicts postopera...
Eligibility Criteria
Inclusion
- Patients in need of emergency or elective abdominal aortic surgery (infra- or suprarenal clamping or EVAR) are eligible for study inclusion.
Exclusion
- Patients unable to give informed consent
- Age \< 18
- Patients not speaking German or French.
Key Trial Info
Start Date :
June 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 23 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03469765
Start Date
June 19 2018
End Date
September 23 2019
Last Update
September 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital
Bern, Switzerland, 3010